Authored By: Sarah
10 Feb 2023

Anti-inflammatory Therapeutics Market Share, Segments, Trends, Growth, and Geography- Analysis, and Forecast 2023-2027

The anti-inflammatory therapeutics market share is forecast to reach USD 39.32 billion, after growing at a CAGR of 6.7% during 2022-2027. The unmet need for safer biologics for RA is analyzed to boost the anti-inflammatory therapeutics market growth. Moreover, the use of gene therapy for RA treatment is the major trend enhancing the overall market demand for anti-inflammatory therapeutics during the forecast period.   

Get a snapshot on the anti-inflammatory therapeutics market analysis: Unlock the Sample Report 

Browse Technavio's 167-page report and in-depth TOC on "Anti-inflammatory Therapeutics Market by application (RA, psoriasis, and MS), drug class (anti-inflammatory biologicals, corticosteroids, and NSAIDs), and geography (North America, Europe, Asia, and Rest of World).

View detailed Table of Contents Here:

Anti-inflammatory Therapeutics Market Share, Segments, Trends, Growth, and Geography- Analysis, and Forecast 2023-2027


  • RA: The market share growth by the RA segment will be significant during the forecast period. RA is an autoimmune and inflammatory disease characterized by joint pain. 

  • Psoriasis

  • MS


  • North America: North America is estimated to contribute 45% to the growth of the global market during the forecast period.

  • Europe 

  • Asia 

  • Rest of World (ROW) 

Drug class: 

  • Anti-inflammatory biologicals

  • Corticosteroids

  • NSAIDs

Key Takeaways: 

  • The anti-inflammatory therapeutics market size will witness a YOY Growth Rate of 5.64% in 2023.  

  • The loss of patents will be a major challenge for the anti-inflammatory therapeutics market during the forecast period. 

  • Major key anti-inflammatory therapeutics market players include: AbbVie Inc., Alvogen Iceland ehf, Amgen Inc., Amneal Pharmaceuticals Inc., Bayer AG, Boehringer Ingelheim International GmbH, Bristol Myers Squibb Co., Cadila Pharmaceuticals Ltd., Cipla Ltd., Eli Lilly and Co., F. Hoffmann-La Roche Ltd, Ferring BV, GlaxoSmithKline Plc, Johnson and Johnson, Lupin Ltd., Mylan N.V, Novartis AG, Teva Pharmaceutical Industries Ltd., Pfizer Inc., and Sanofi SA 

  • The report illustrates the lifecycle of the market, focusing on the adoption rates of the major regions such as the North America, Europe, Asia, and Rest of World. 

Download the PDF sample report for highlights on the market size, growth momentum, regional growth opportunities, vendor analysis, and other factors influencing the market growth. 

Key data covered in the Anti-inflammatory Therapeutics Market report 

  • Precise market size estimation during the forecast period 2023-2027.  

  • CAGR of the anti-inflammatory therapeutics market forecast during 2023-2027.  

  • Market-level data on units, average selling prices, and values of the anti-inflammatory therapeutics market share.  

  • Prediction of the upcoming trends, drivers, and factors that challenge the growth of the anti-inflammatory therapeutics market.  

  • Anti-inflammatory therapeutics industry growth across North America, Europe, Asia, and Rest of World. 

Read News Read Less
Interested in this report?
Get your sample now!